Home/Filings/4/0000950170-24-134239
4//SEC Filing

Feltquate David 4

Accession 0000950170-24-134239

CIK 0001808865other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 6:00 PM ET

Size

4.9 KB

Accession

0000950170-24-134239

Insider Transaction Report

Form 4
Period: 2024-12-06
Feltquate David
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-12-06+47,00047,000 total
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 6, 2026, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1
  • filerCIK 0002031518

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:00 PM ET
Size
4.9 KB